WallStreetZenWallStreetZen

NASDAQ: DBVT
Dbv Technologies Sa Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for DBVT

Based on 4 analysts offering 12 month price targets for Dbv Technologies Sa

Min Forecast
$40.00+84.42%
Avg Forecast
$46.00+112.08%
Max Forecast
$51.00+135.13%

Should I buy or sell DBVT stock?

Based on 4 analysts offering ratings for Dbv Technologies Sa.

Strong Buy
Strong Buy
2 analysts 50%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although DBVT's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates DBVT as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their DBVT stock forecasts and price targets.

DBVT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-17
lockedlocked$00.00+00.00%2025-12-17Find Out Why
lockedlocked$00.00+00.00%2025-12-17
lockedlocked$00.00+00.00%2025-12-17Find Out Why

1 of 1

Forecast return on equity

Is DBVT forecast to generate an efficient return?

Company
N/A
Industry
275.71%
Market
238.37%

Forecast return on assets

Is DBVT forecast to generate an efficient return on assets?

Company
N/A
Industry
114.68%

DBVT earnings per share forecast

What is DBVT's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.04
Avg 2 year Forecast
-$0.13

DBVT revenue forecast

What is DBVT's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$875.7M+15,812.59%
Avg 2 year Forecast
$228.4M+4,050.46%
Avg 3 year Forecast
$94.8M+1,622.01%
DBVT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DBVT revenue growth forecast

How is DBVT forecast to perform vs Biotechnology companies and vs the US market?

Company
158.23%
Industry
119.45%
Market
23.3%
DBVT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DBVT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DBVT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
DBVT$21.69$46.00+112.08%Strong Buy
GYRE$7.82$17.00+117.39%Strong Buy
MDXG$5.09$10.00+96.46%Strong Buy
ARVN$11.84$13.83+16.88%Strong Buy
KALV$15.12$33.33+120.46%Buy
View Top Biotech Stocks

Dbv Technologies Sa Stock Forecast FAQ

Is Dbv Technologies Sa Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: DBVT) stock is to Strong Buy DBVT stock.

Out of 4 analysts, 2 (50%) are recommending DBVT as a Strong Buy, 2 (50%) are recommending DBVT as a Buy, 0 (0%) are recommending DBVT as a Hold, 0 (0%) are recommending DBVT as a Sell, and 0 (0%) are recommending DBVT as a Strong Sell.

If you're new to stock investing, here's how to buy Dbv Technologies Sa stock.

What is DBVT's earnings growth forecast for 2026-2027?

(NASDAQ: DBVT) Dbv Technologies Sa's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 61.98%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.85%.

Dbv Technologies Sa's earnings in 2026 is -$125,133,000.On average, 4 Wall Street analysts forecast DBVT's earnings for 2026 to be -$6,223,381, with the lowest DBVT earnings forecast at -$213,658,146, and the highest DBVT earnings forecast at $277,008,108.

In 2027, DBVT is forecast to generate -$22,204,618 in earnings, with the lowest earnings forecast at -$21,545,075 and the highest earnings forecast at -$23,084,009.

What is DBVT's revenue growth forecast for 2026-2028?

(NASDAQ: DBVT) Dbv Technologies Sa's forecast annual revenue growth rate of 158.23% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 119.45%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.3%.

Dbv Technologies Sa's revenue in 2026 is $5,503,000.On average, 3 Wall Street analysts forecast DBVT's revenue for 2026 to be $148,087,722,750, with the lowest DBVT revenue forecast at $143,689,077,520, and the highest DBVT revenue forecast at $153,952,583,057. On average, 3 Wall Street analysts forecast DBVT's revenue for 2027 to be $38,625,550,580, with the lowest DBVT revenue forecast at $22,649,386,993, and the highest DBVT revenue forecast at $56,044,253,337.

In 2028, DBVT is forecast to generate $16,025,544,764 in revenue, with the lowest revenue forecast at $15,549,489,926 and the highest revenue forecast at $16,660,228,176.

What is DBVT's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: DBVT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 114.68%.

What is DBVT's Price Target?

According to 4 Wall Street analysts that have issued a 1 year DBVT price target, the average DBVT price target is $46.00, with the highest DBVT stock price forecast at $51.00 and the lowest DBVT stock price forecast at $40.00.

On average, Wall Street analysts predict that Dbv Technologies Sa's share price could reach $46.00 by Dec 17, 2026. The average Dbv Technologies Sa stock price prediction forecasts a potential upside of 112.08% from the current DBVT share price of $21.69.

What is DBVT's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: DBVT) Dbv Technologies Sa's current Earnings Per Share (EPS) is -$5.15. On average, analysts forecast that DBVT's EPS will be -$0.04 for 2026, with the lowest EPS forecast at -$1.26, and the highest EPS forecast at $1.64. In 2027, DBVT's EPS is forecast to hit -$0.13 (min: -$0.13, max: -$0.14).

What is DBVT's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: DBVT) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.